REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
24/05/2025
Voltar para busca
Dado oficial do USPTO
PATHOMICS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
PATHOMICS
ST13
US500000079176495Classe
5, 35, 42
Pedido
79176495
Registro
4962140
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
41
Atualização mais recente
25/05/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 35, 42
Data de depósito
22/01/2015
Data de registro
24/05/2016
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
07/11/2022
Última transação
25/05/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
707
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
London, GB
Examinador
CROWLEY, SEAN
Unidade examinadora
M70
Titulares e representantes
Titulares
HVIVO SERVICES LIMITED
Retroscreen Virology Limited
Representantes
Mainak H. Mehta Procopio, Cory, Hargreaves & Savitch LLP
Classificação técnica
Classes Nice
Classe 5Classe 35Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical and medical compositions for human and/or veterinary usefor the treatment of dermatologicalcardiovascularhematologicalbonerespiratorycentral nervous systemendocrinologicalcirculatorygastroenterologicalhormonal and diabetic disorderscoughscoldsinfluenzaheadachesstomach and digestive disordersmuscular and/or rheumatic disordersanti-inflammatory agentsimmune system disorders and related diseasesallergic reactionsmetabolic disordersanti-infectivesoccular disordersfor use in oncology; vaccines for human beings and/or animals; adjuvants for use with vaccines; biological laboratory preparations for medical and/or veterinary purposesfor the treatment of dermatologicalcardiovascularhematologicalbonerespiratorycentral nervous systemendocrinologicalcirculatorygastroenterologicalhormonal and diabetic disorderscoughscoldsinfluenzaheadachesstomach and digestive disordersmuscular and/or rheumatic disordersanti-inflammatory agentsimmune system disorders and related diseasesallergic reactionsmetabolic disordersanti-infectivesoccular disordersfor use in oncology; chemical preparations and reagents for medicalpharmaceutical and veterinary purposesfor the treatment of dermatologicalcardiovascularhematologicalbonerespiratorycentral nervous systemendocrinologicalcirculatorygastroenterologicalhormonal and diabetic disorderscoughscoldsinfluenzaheadachesstomach and digestive disordersmuscular and/or rheumatic disordersanti-inflammatory agentsimmune system disorders and related diseasesallergic reactionsmetabolic disordersanti-infectivesoccular disordersfor use in oncology; viruses for the treatment of humans and/or animals; diagnostic preparations for medical purposes; in-vitro diagnostic preparations for medical purposes; in-vivo diagnostic preparations for medical purposes
Classe 35
Investigation and research services relating to cost and business efficiencyall relating to pharmaceuticalsmedicinemedicinesvaccinessciencebacteriologytoxicologychemistryclinicologyoncologybiochemistry and biotechnology; systemization and compilation of medical information into computer databases; business statistical information all relating to pharmaceuticalsmedicinemedicinesvaccinessciencebacteriologytoxicologychemistryclinicologyoncologybiochemistry and biotechnology; registration services for diagnostic testing; product demonstration services in the field of diagnostic testing; computer database management servicesdatabase management services that allow for information storage in the fields of diagnostic testing and resultsdatabase management of medicalhospitalinsurance and billing records and information storage and retrieval services in the fields of diagnostic testing and preparations for the treatmentmonitoring or diagnosis of disease; trade information services in the fields of medicalhealthclinical care; database management of diagnostic testing and resultsdatabase management of medicalhospitalinsurance or billing records; collation and provision of business information for the purpose of providing referral services in the fields of medicalhealth or clinical care; collation and provision of business information in the fields of medicine and pharmacy; collation and provision of business information regarding medical and pharmaceutical testing procedures; collation and provision of business information regarding disease conditions and disease prevention; collation and provision of business information regarding medicalhospitalinsurance or billing records
Classe 42
Medical research services; conducting clinical trials for others; medical research laboratory services; medical research laboratory services for the analysis of samples taken from patients; scientific analysis and research services; product development relating to pharmaceuticalsmedicinesmedicaments and veterinary products; medical and health care research servicesclinical testing servicesphysician testing services for assisting pharmacistspharmacy testing servicesmedical laboratory and testing services; medical research into the causes and treatment of influenza and the common cold
Publicações
Histórico de despachos e eventos da marca no USPTO.
41 publicações encontradas
RNWL
INTERNATIONAL REGISTRATION RENEWED
12/09/2024
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
16/09/2023
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
08/08/2023
INPC
INVALIDATION PROCESSED
08/08/2023
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
07/07/2023
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
07/11/2022
71.P
REGISTERED - PARTIAL SEC 71 ACCEPTED
07/11/2022
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
31/10/2022
PR71
POST REGISTRATION ACTION MAILED - SEC.71
24/05/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
23/05/2022
ES71
TEAS SECTION 71 RECEIVED
11/11/2021
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
24/05/2021
NREP
NEW REPRESENTATIVE AT IB RECEIVED
09/05/2019
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
24/11/2016
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
16/09/2016
FICS
FINAL DISPOSITION NOTICE SENT TO IB
25/08/2016
FIMP
FINAL DISPOSITION PROCESSED
25/08/2016
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
24/08/2016
R.PR
REGISTERED-PRINCIPAL REGISTER
24/05/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/03/2016
PUBO
PUBLISHED FOR OPPOSITION
08/03/2016
GPNX
NOTIFICATION PROCESSED BY IB
04/03/2016
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
17/02/2016
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
17/02/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
17/02/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
01/02/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
26/01/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
25/01/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
25/01/2016
ALIE
ASSIGNED TO LIE
25/01/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/01/2016
RFNT
REFUSAL PROCESSED BY IB
31/12/2015
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/12/2015
RFRR
REFUSAL PROCESSED BY MPU
04/12/2015
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/12/2015
CNRT
NON-FINAL ACTION WRITTEN
01/12/2015
MAFR
APPLICATION FILING RECEIPT MAILED
25/11/2015
DOCK
ASSIGNED TO EXAMINER
21/11/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
21/11/2015
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
19/11/2015
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace PATHOMICS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.